G protein-coupled receptors in natural killer cells

被引:60
作者
Maghazachi, AA [1 ]
机构
[1] Univ Oslo, Dept Anat, Inst Basic Med Sci, N-0317 Oslo, Norway
关键词
chemokines; lysolipids; cancer; chemotaxis; inflammation;
D O I
10.1189/jlb.0103019
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Natural killer (NK) cells are capable of killing tumor as well as virally infected cells. How these cells migrate toward the infected sites in the body is not completely understood. Chemokine receptors that belong to the heptahelical family of receptors and characteristic ally bind heterotrimeric G proteins are present in most NK cells. Recent results showed that resting NK cells highly express constitutive chemokine receptors (CCR4, CCR7, CXCR4, and CX(3)CR1) with low expression of a limited repertoire of inflammatory chemokine receptors (CCR1 and CXCR3). However, only a subset of these cells expressing the CD56(dim) and adhesion molecule(high) phenotype is capable of in vivo binding to vascular endothelium. Under pathological conditions where inflammatory cytokines are present, these cells are induced to express inflammatory chemokine receptors. Resting as well as activated NK cells also express receptors for another member of the heptahelical family of receptors that bind phosphorylated or glycosylated lysolipids. These include sphingosine I-phosphate (S1P)(1), S1P(4), and S1P(5), the receptors for S1P; lysophosphatidic acid (LPA)(1), LPA(2), and LPA(3), the receptors for LPA; and T cell death-associated gene 8, the receptor for psychosine. Similar to chemokines, S I P, LPA, and psychosine induce the chemotaxis of NK cells through heterotrimeric G proteins. However, in contrast to chemokines, which enhance the cytotoxicity of NK cells, lysolipids inhibit this function. We hope that gaining knowledge regarding the distribution of activated NK cells toward the sites of tumor growth or virally infected sites will give an advantage in designing strategies using these cells as tools for the prevention and treatment of immunodeficiencies.
引用
收藏
页码:16 / 24
页数:9
相关论文
共 114 条
[1]  
Al-Aoukaty A, 1998, IMMUNOLOGY, V95, P618
[2]   INDUCTION OF NATURAL-KILLER-CELL MIGRATION BY MONOCYTE CHEMOTACTIC PROTEIN-1, PROTEIN-2 AND PROTEIN-3 [J].
ALLAVENA, P ;
BIANCHI, G ;
ZHOU, D ;
VANDAMME, J ;
JILEK, P ;
SOZZANI, S ;
MANTOVANI, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (12) :3233-3236
[3]   INVIVO DISTRIBUTION AND TISSUE LOCALIZATION OF HIGHLY PURIFIED RAT LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS [J].
ALMAGHAZACHI, A ;
HERBERMAN, RB ;
VUJANOVIC, NL ;
HISERODT, JC .
CELLULAR IMMUNOLOGY, 1988, 115 (01) :179-194
[4]   Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors [J].
Arase, H ;
Mocarski, ES ;
Campbell, AE ;
Hill, AB ;
Lanier, LL .
SCIENCE, 2002, 296 (5571) :1323-1326
[5]   Macrophage infiltration in human non-small-cell lung cancer: the role of CC chemokines [J].
Arenberg, DA ;
Keane, MP ;
DiGiovine, B ;
Kunkel, SL ;
Strom, SRB ;
Burdick, MD ;
Iannettoni, MD ;
Strieter, RM .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2000, 49 (02) :63-70
[6]   ACCUMULATION OF ADOPTIVELY TRANSFERRED ADHERENT, LYMPHOKINE-ACTIVATED KILLER-CELLS IN MURINE METASTASES [J].
BASSE, P ;
HERBERMAN, RB ;
NANNMARK, U ;
JOHANSSON, BR ;
HOKLAND, M ;
WASSERMAN, K ;
GOLDFARB, RH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (02) :479-488
[7]   ESTABLISHMENT OF CELL-TO-CELL CONTACT BY ADOPTIVELY TRANSFERRED ADHERENT LYMPHOKINE-ACTIVATED KILLER-CELLS WITH METASTATIC MURINE MELANOMA-CELLS [J].
BASSE, PH ;
NANNMARK, U ;
JOHANSSON, BR ;
HERBERMAN, RB ;
GOLDFARB, RH .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (13) :944-950
[8]   Natural killer cells in antiviral defense: Function and regulation by innate cytokines [J].
Biron, CA ;
Nguyen, KB ;
Pien, GC ;
Cousens, LP ;
Salazar-Mather, TP .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :189-220
[9]   Human natural killer cells produce abundant macrophage inflammatory protein-1 in response to monocyte-derived cytokines [J].
Bluman, EM ;
Bartynski, KJ ;
Avalos, BR ;
Caligiuri, MA .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (12) :2722-2727
[10]  
BOTTAZZI B, 1985, J IMMUNOL, V134, P2316